Symbol="MRNS"
AssetType="Common Stock"
Name="Marinus Pharmaceuticals Inc"
Description="Marinus Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapies to treat rare seizure disorders. The company is headquartered in Radnor, Pennsylvania."
CIK="1267813"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 N RADNOR CHESTER RD, SUITE 250, RADNOR, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="504469000"
EBITDA="-126154000"
PERatio="None"
PEGRatio="0"
BookValue="1.632"
DividendPerShare="0"
DividendYield="0"
EPS="-0.66"
RevenuePerShareTTM="0.506"
ProfitMargin="-1.623"
OperatingMarginTTM="-5.95"
ReturnOnAssetsTTM="-0.439"
ReturnOnEquityTTM="-0.561"
RevenueTTM="21672000"
GrossProfitTTM="-55943000"
DilutedEPSTTM="-0.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.268"
AnalystTargetPrice="23.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.21"
PriceToBookRatio="2.654"
EVToRevenue="5.83"
EVToEBITDA="-37.38"
Beta="1.299"
num_52WeekHigh="11.15"
num_52WeekLow="3.465"
num_50DayMovingAverage="9.14"
num_200DayMovingAverage="6.7"
SharesOutstanding="50548000"
DividendDate="2020-09-23"
ExDividendDate="None"
symbol="MRNS"
open="10.34"
high="10.35"
low="9.63"
price="9.67"
volume="648453.00"
latest_trading_day="2023-07-12"
previous_close="10.28"
change="-0.61"
change_percent="-5.9339%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="755059"
Change_recent_avg="0.03"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.29"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="1165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="1005"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0167.jpeg"
image_positive_thumbnail_id_2="994"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
